GB202116412D0 - Methods for detecting and predicting breast cancer - Google Patents

Methods for detecting and predicting breast cancer

Info

Publication number
GB202116412D0
GB202116412D0 GBGB2116412.4A GB202116412A GB202116412D0 GB 202116412 D0 GB202116412 D0 GB 202116412D0 GB 202116412 A GB202116412 A GB 202116412A GB 202116412 D0 GB202116412 D0 GB 202116412D0
Authority
GB
United Kingdom
Prior art keywords
detecting
methods
breast cancer
predicting breast
predicting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2116412.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sola Diagnostics GmbH
Original Assignee
Sola Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sola Diagnostics GmbH filed Critical Sola Diagnostics GmbH
Priority to GBGB2116412.4A priority Critical patent/GB202116412D0/en
Publication of GB202116412D0 publication Critical patent/GB202116412D0/en
Priority to PCT/EP2022/081924 priority patent/WO2023084104A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB2116412.4A 2021-11-15 2021-11-15 Methods for detecting and predicting breast cancer Ceased GB202116412D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2116412.4A GB202116412D0 (en) 2021-11-15 2021-11-15 Methods for detecting and predicting breast cancer
PCT/EP2022/081924 WO2023084104A1 (en) 2021-11-15 2022-11-15 Methods for detecting and predicting breast cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2116412.4A GB202116412D0 (en) 2021-11-15 2021-11-15 Methods for detecting and predicting breast cancer

Publications (1)

Publication Number Publication Date
GB202116412D0 true GB202116412D0 (en) 2021-12-29

Family

ID=79163732

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2116412.4A Ceased GB202116412D0 (en) 2021-11-15 2021-11-15 Methods for detecting and predicting breast cancer

Country Status (2)

Country Link
GB (1) GB202116412D0 (en)
WO (1) WO2023084104A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996006641A1 (en) 1994-08-29 1996-03-07 Prizm Pharmaceuticals, Inc. Conjugates of vascular endothelial growth factor with targeted agents
WO2013033627A2 (en) * 2011-09-01 2013-03-07 The Regents Of The University Of California Diagnosis and treatment of arthritis using epigenetics
EP3194624B1 (en) * 2014-09-15 2022-02-16 Garvan Institute of Medical Research Methods for diagnosis, prognosis and monitoring of breast cancer and reagents therefor
GB201711782D0 (en) * 2017-07-21 2017-09-06 Ucl Business Plc Diagnostic and Prognostic methods
WO2019055505A1 (en) * 2017-09-13 2019-03-21 Christiana Care Health Services, Inc. Identification of epigenetic signatures indicating breast cancer
GB201908591D0 (en) * 2019-06-14 2019-07-31 Ucl Business Plc Methods for cancer diagnosis

Also Published As

Publication number Publication date
WO2023084104A1 (en) 2023-05-19

Similar Documents

Publication Publication Date Title
HK1251018A1 (en) Detecting mutations for cancer screening and fetal analysis
IL288970A (en) Methods of detecting and predicting breast cancer
EP3524689A4 (en) Method for predicting the prognosis of breast cancer patient
EP2488666A4 (en) Biomarkers and identification methods for the early detection and recurrence prediction of breast cancer using nmr
IL254119A0 (en) Whole blood based mrna markers for predicting prostate cancer and methods of detecting the same
IL276748A (en) Methods for prostate cancer detection and treatment
EP3775906C0 (en) Metabolite-based breast cancer detection and diagnosis
EP3524690C0 (en) Method for predicting effectiveness of chemotherapy in breast cancer patients
GB201905111D0 (en) Novel biomarkers and diagnostic profiles for prostate cancer
SG11202109835WA (en) Methods for predicting prostate cancer and uses thereof
GB202009222D0 (en) Methods for detecting and predicting cancer
GB202009220D0 (en) Methods for detecting and predicting cancer
EP3425392A4 (en) Method for detecting castration-resistant prostate cancer and detection reagent
GB202116412D0 (en) Methods for detecting and predicting breast cancer
GB202009217D0 (en) Methods for detecting and predicting breast cancer
GB202107412D0 (en) Methods for detecting and predicting cancer and/or CIN3
GB201915464D0 (en) Novel biomarkers and diagnostic profiles for prostate cancer
IL214476A0 (en) Method for predicting breast and ovarian cancer risk
GB201905861D0 (en) Methods of detecting cancer
GB202009224D0 (en) Methods for detecting and predicting cancer and/or cin3
GB202311999D0 (en) Methods for detecting cancer
IL288421A (en) Breast cancer detection methods
GB202019682D0 (en) Biomarkers for detecting cancer
GB202008450D0 (en) Methods for predicting treatment response in cancers
GB202214114D0 (en) Detecting cancer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)